Purpose: To report early experience with a new endovascular graft developed for aortic arch aneurysm repair in patients unfit for open surgery. Case Report: Three consecutive men (62, 74, and 69 years old) at high risk for open repair were treated for postdissection aortic arch aneurysms using a custom-made 3 inner branched endovascular graft. The 2 proximal branches are antegrade and perfuse the innominate artery and the left common carotid artery; the third branch is retrograde and perfuses the left subclavian artery. The latter is preloaded with a catheter and wire to aid cannulation. Technical success was achieved in each case. The mean procedure time, fluoroscopy duration, and contrast volume were 180 minutes, 35 minutes, and 145 mL, respectively. The perioperative period was uneventful. All branches were patent on 6-month computed tomography and duplex ultrasound imaging. Conclusion: This new patient-specific device allows total endovascular revascularization of the supra-aortic trunks during arch repair. These encouraging results support its more widespread use.
Introduction
The introduction of endovascular repair for aortic arch disease offers an alternative treatment to open surgery for patients with extensive comorbidities and those who have undergone previous thoracotomy. The Arch Branch Endovascular Graft (Cook Medical, Brisbane, Australia) is a third-generation stent-graft for the aortic arch. 1 The design is based on the experience gained from previous strategies for endovascular treatment of disease in the aortic arch. Herein is described a new version of this device that has 3 inner branches, one to revascularize each of the supra-aortic trunks.
One of the limitations of the predicate 2-branch design was that an additional procedure was required, either at the time of the arch branch repair or as a first stage, to connect the left subclavian artery (LSA) to the left common carotid artery (LCCA) via a transposition or bypass graft. 2 Endovascular revascularization of the LSA during the arch branch procedure obviates the need for an additional anesthesia and avoids injury to surrounding structures, such as nerves and lymphatics. A single procedure is especially beneficial in patients with aortic arch disease, as they tend to be fragile and at high operative risk. The third branch incorporated into the latest design is a retrograde branch that overcomes the previous constraints. The initial arch branch stent-graft and this new device are currently not approved by the Food and Drug Administration. The use of the device was approved by our hospital's institutional review committee, and all patients gave informed consent to treatment.
Case Report
Three consecutive men (62, 74, and 69 years old) were treated for postdissection aortic arch aneurysms ( Table 1) . Two of 3 patients had chronic renal insufficiency with estimated glomerular rates of 24 and 38 mL/min/1.73 m 2 , respectively. All patients presented with postdissection aneurysm and a previous history of acute type A dissection requiring emergent ascending aortic repair. The open surgical alternative would have been a redo sternotomy with arch replacement and elephant trunk procedure under deep hypothermia and cerebral perfusion. While this is our first line therapy in such cases, it was ruled out in these patients because of their physiological conditions.
The delivery system for the new 3 inner arch branch device incorporates a 22-to 24-F delivery sheath. The 2 proximal branches are antegrade and perfuse the innominate artery and the LCCA; the third branch is retrograde and perfuses the LSA. The latter is preloaded with a catheter and wire to aid cannulation. Gold markers are positioned on the endograft to locate the branches.
The initial steps of the procedure are similar to the implantation of an arch branch stent-graft. 1 After deployment of the innominate artery and LCCA bridging stents, a second Lunderquist wire is advanced into the preloaded LSA branch catheter. The delivery system of the branched endograft and its Lunderquist wire are retrieved, and a 22-F, 30-cm sheath is advanced over the second Lunderquist wire. A 10-F, 80-cm sheath (Flexor; Cook Medical, Bloomington, IN, USA) is then advanced through the 22-F sheath, over the Lunderquist wire, directly into the LSA branch. Its dilator is retrieved and its valve punctured to advance a second wire (floppy) and a 100-cm angled catheter, which are used to catheterize the LSA. Once the catheter has been advanced into the left axillary artery, the floppy wire is replaced by a stiffer wire (Rosen or Amplatz). The Lunderquist wire is then retrieved and a bridging self-expanding covered stent advanced (Fluency; Bard Peripheral Vascular, Tempe, AZ, USA). The covered stent is sized and positioned to completely overlap the inner branch on one side and to provide maximum overlap in the LSA without covering the origin of the left vertebral artery. The bridging stents were relined with self-expanding nitinol stents to provide more radial force and a more "kink resistant" branch.
Technical success was achieved in all cases. The maximum diameters of the arch dissecting aneurysms were 60 mm in 2 patients and 78 mm in the third. The preloaded system was not used in the first case because the preloaded catheter was accidentally retrieved during trigger wire deployment. The LSA inner branch was still easily accessed from the femoral approach because it is downward facing and on the greater curve of the aorta. The procedure length (skin to skin) was 180 minutes in the first 2 patients and 155 minutes in the third. The fluoroscopy duration was 32, 35, and 64 minutes. The first 2 patients were obese and thus required much more time to perform the groin and neck incisions. The branches were more challenging to cannulate in the last patient.
The stays in the intensive care unit were 1, 2, and 3 days, respectively. Two patients were discharged home, one on postoperative day 9 and the other at day 12; 1 patient was transferred to intermediate care for further rehabilitation at day 10 before returning home. No cerebral, cardiac, or renal event occurred during the perioperative period. All branches were patent on the postoperative (Figure 3 ) and 6-month imaging, with a decrease in maximum aortic diameters at 6 months ( Figure 4 ).
Discussion
The first experience of a 3-branched arch device was described by Inoue et al 2 in 1999, but no update is available. The cases in this report of total endovascular aortic arch repair were performed using a new arch branch endovascular graft incorporating 3 inner branches. The use of this new device offers a rapid learning curve as it is adapted from the first inner branched arch endograft 1 and from the preloaded system of endografts manufactured by Cook Australia. The cases reported here were associated with good technical success and early results.
During open and endovascular aortic arch repair, the LSA is revascularized to lower the risk of stroke and spinal cord ischemia. 3 The third branch in this new device avoids revascularization of the LSA using bypass or transposition either prior to or during the same procedure, thereby reducing the complexity of the procedure and the physiological burden to the patient. We now perform total endovascular arch branch repair without the need for a staged approach. (B) In this scan from another patient, the true lumen is highlighted in red and the false lumen in blue. The proximal bridging stent was implanted in the right common carotid (RCCA) because the innominate trunk was dissected; a RCCA to right subclavian artery bypass was therefore performed (not seen in figure) .
During the procedure 2 small common carotid artery cutdowns are performed, which allows carotid clamping while inserting and implanting the bridging stents to the innominate and LCCA. With this access, the path is straight to the inner branches and much easier compared to a right or left axillary approach; it also allows the bridging stent delivery systems to be advanced smoothly.
The LSA branch has a preloaded system that can be accessed from a femoral approach rather than via a LSA or brachial approach. The LSA inner branch is downward facing and on the greater curve of the aorta, which allows easy cannulation, even in the absence of the preloaded system, as was seen in one of the cases presented. Despite this design, flow in the LSA after treatment with the retrograde branch was evaluated using duplex ultrasound and found to be normal. The retrograde rather than antegrade design also provides more space in the arch lumen and can accommodate future intervention of the visceral aorta from a brachial approach.
The use of a branched rather than fenestrated approach also offers benefits in complex arch anatomy, for example, branches provide more flexibility as they do not need to be accurately positioned in front of the supra-aortic trunk origins; the bridging stents can adapt to clock position discrepancies and are available in various lengths. The precurved inner cannula and the "greater curvature" endograft attachment to the inner cannula also self-orient the endograft. Thus, focus is needed only on the longitudinal position of the branches during deployment, which further improves accuracy.
One of the difficulties with the LSA branch is the steep angle that can be formed between the endograft branch and target vessel. We currently use a self-expanding covered bridging stent relined with a nitinol stent for this purpose, but in future iterations of the procedure it is likely that a specific stent for this branch will be devised, in common with other manufacturers who have developed thoracic devices with a LSA branch. One of the benefits of the branch device implanted in these cases is its ease of use; for example, it does not require snaring a wire in the arch or tracking a delivery system over 2 wires.
Conclusion
A new branched arch endovascular graft with 3 inner branches has been used to treat arch dissecting aneurysms in patients deemed unfit for open surgery. These cases demonstrate technical feasibility and good early outcomes. Further evaluation is required to confirm these promising results. 
